Fabio Marra

Active 1992–2025

175
Papers
25,542
Citations
91
h-index
165
i10-index

Citations

Citations per year for Fabio Marra1994: 3 citations1995: 8 citations1996: 9 citations1997: 13 citations1998: 46 citations1999: 61 citations2000: 78 citations2001: 79 citations2002: 103 citations2003: 155 citations2004: 159 citations2005: 163 citations2006: 130 citations2007: 161 citations2008: 278 citations2009: 274 citations2010: 269 citations2011: 244 citations2012: 211 citations2013: 200 citations2014: 235 citations2015: 222 citations2016: 207 citations2017: 221 citations2018: 228 citations2019: 722 citations2020: 725 citations2021: 879 citations2022: 895 citations2023: 833 citations2024: 1,213 citations2025: 539 citations2026: 18 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,350 citing papers, 19.1% of this breakdownChina: 1,824 citing papers, 14.8% of this breakdownItaly: 1,273 citing papers, 10.3% of this breakdownGermany: 713 citing papers, 5.8% of this breakdownUnited Kingdom: 703 citing papers, 5.7% of this breakdownJapan: 487 citing papers, 3.9% of this breakdownFrance: 460 citing papers, 3.7% of this breakdownSpain: 435 citing papers, 3.5% of this breakdownSouth Korea: 308 citing papers, 2.5% of this breakdownCanada: 271 citing papers, 2.2% of this breakdownAustralia: 234 citing papers, 1.9% of this breakdownIndia: 208 citing papers, 1.7% of this breakdown
0%19.1%Other 24.9%

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology3.9%
  • Neuroscience1.2%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Agricultural and Biological Sciences0.5%
  • Other1.8%

Topics

  • Liver Disease Diagnosis and Treatment17%
  • Liver Disease and Transplantation5.3%
  • Liver physiology and pathology4.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.9%
  • Liver Diseases and Immunity3.1%
  • Diet, Metabolism, and Disease3%
  • Other62.8%

Coauthors

All papers

Open in search
  1. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger and 10 more - Nature 2021 cited by 1,280

  2. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 454

  3. Lipotoxicity and the gut-liver axis in NASH pathogenesis

    Authors: , - Journal of Hepatology 2017 cited by 834

  4. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier and 35 more - Journal of Hepatology 2021 cited by 353

  5. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

    Authors: , , , , - Cells 2021 cited by 261

  6. Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH)

    Authors: , , , , , , , , , , , - Liver International 2021 cited by 158

  7. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giulio Marchesini, Fabio Farinati - Gut 2021 cited by 169

  8. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 167

  9. Roles for Chemokines in Liver Disease

    Authors: , - Gastroenterology 2014 cited by 837

  10. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 207

  11. Metabolic reprogramming in cholangiocarcinoma

    Authors: , , , , - Journal of Hepatology 2022 cited by 172

  12. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

    Authors: , , , , , , , , , , , , - Journal of Gastroenterology and Hepatology 2009 cited by 629

  13. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victoria Mulcahy, Jinyoung Byan, Younghun Han, Richard Sandford, Konstantinos N. Lazaridis, Christopher I. Amos, Gideon M. Hirschfield, Michael F. Seldin, Pietro Invernizzi, Katherine A. Siminovitch, Xiong Ma, Minoru Nakamura, George Mells, Katherine A. Siminovitch, Gideon M. Hirschfield, Andrew L. Mason, Catherine Vincent, Gang Xie, Jinyi Zhang, Ruqi Tang, Xiong Ma, Zhiqiang Li, Yongyong Shi, Andrea Affronti, Piero Luigi Almasio, Domenico Alvaro, Pietro Andreoné, Angelo Andriulli, Francesco Azzaroli, Pier Maria Battezzati, A. Benedetti, Maria Consiglia Bragazzi, Maurizia Rossana Brunetto, Savino Bruno, Vincenza Calvaruso, Vincenzo Cardinale, Giovanni Casella, Nora Cazzagon, Antonio Ciaccio, B. Coco, Agostino Colli, Guido Colloredo, Massimo Colombo, Sílvia Colombo, Laura Cristoferi, Carmela Cursaro, Lory Saveria Crocè, Andrea Crosignani, Daphne D’Amato, Francesco Donato, G. Elia, Luca Fabris, S. Fagiuoli, Carlo Ferrari, Annarosa Floreani, Andrea Galli, Edoardo G. Giannini, Ignazio Grattagliano, Pietro Lampertico, Ana Lleò, Federica Malinverno, Clara Mancuso, Fabio Marra, Marco Marzioni, Sara Massironi, Alberto Mattalia, Luca Miele, Chiara Milani, Lorenzo Morini, Filomena Morisco and 368 more - Journal of Hepatology 2021 cited by 184

  14. Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takuya Sho, Beodeul Kang, Antonio D’Alessio, Takashi Kumada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiro Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, T. Nishimur, Takeshi Hatanaka, Satoru Kakizaki, Naohiko Shimada, Kazuhito Kawata, Takaaki Tanaka, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, T. Arai, Michitaka Imai, Atsushi Naganuma, Yuichiro Koizumi, Shinichiro Nakamura, Kouji Joko, Hiroko Iijima, Yoichi Hiasa, Federica Pedica, Francesco De Cobelli, Francesca Ratti, Luca Aldrighetti, Masatoshi Kudo, Stefano Cascinu, Andrea Casadei‐Gardini - ESMO Open 2022 cited by 130

  15. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Mario Scartozzi, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Valentina Burgio, Mara Persano, Angelo Della Corte, Francesca Ratti, Francesco De Cobelli, Luca Aldrighetti, Stefano Cascinu, Alessandro Cucchetti - European Journal of Cancer 2022 cited by 129

  16. The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells

    Authors: , , , , , , - Hepatology 2017 cited by 259

  17. An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4

    Authors: , , , , , , , , , , , , , - The Journal of Experimental Medicine 2003 cited by 747

  18. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis†

    Authors: , , , , , , , , - Hepatology 2008 cited by 422

  19. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Di Costanzo, Fabio Marra, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Claudia Campani, Elisabeth Amadeo, Federico Rossari, Valentina Burgio, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini - European Journal of Cancer 2023 cited by 56

  20. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentina Liakina, Catherine Vincent, Cynthia Levy, Peter K. Gregersen, Italian PBC Genetics Study Group, Piero Luigi Almasio, Domenico Alvaro, Pietro Andreoné, Angelo Andriulli, Cristina Barlassina, Pier Maria Battezzati, A. Benedetti, Francesca Bernuzzi, Ilaria Bianchi, Maria Consiglia Bragazzi, Maurizia Rossana Brunetto, Savino Bruno, Giovanni Casella, B. Coco, Agostino Colli, Massimo Colombo, Sílvia Colombo, Carmela Cursaro, Lory Saveria Crocè, Andrea Crosignani, Maria Francesca Donato, G. Elia, Luca Fabris, Carlo Ferrari, Annarosa Floreani, Barbara Foglieni, Rosanna Fontana, Andrea Galli, Roberta Lazzari, Fabio Salvatore Macaluso, Federica Malinverno, Fabio Marra, Marco Marzioni, Alberto Mattalia, R. Montanari, Lorenzo Morini, Filomena Morisco, Hani S. Mousa, Luigi Muratori, Paolo Muratori, Grazia Anna Niro, Vincenzo Ostilio Palmieri, Antonio Picciotto, Mauro Podda, Piero Portincasa, Vincenzo Ronca, F. Rosina, Sonia Rossi, Ilaria Sogno, Giancarlo Spinzi, Marta Spreafico, Mario Strazzabosco, Sonia Tarallo, Mirko Tarocchi, Claudio Tiribelli, Pierluigi Toniutto, Maria Cristina Vinci, Massimo Zuin, Chin Lye Ch’ng, Mesbah Rahman, Tom Yapp, Richard Sturgess, Christopher Healey, Marek Czajkowski, Anton Gunasekera and 362 more - Nature Communications 2015 cited by 310

  21. Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

    Authors: , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2017 cited by 160

  22. Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡

    Authors: , , , , , , , , , , , , - Hepatology 2007 cited by 716

  23. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells

    Authors: , , , , , , , , , , - Journal of Hepatology 2009 cited by 234

  24. Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

    Authors: , , , , , , , , , , , , , , , - Hepatology 2016 cited by 212